论文部分内容阅读
AIM: To clarify the effects of the xeroderma pigmentosum group D(XPD) Asp312 Asn and Lys751 Gln gene polymorphisms on the risk of esophageal cancer(EC).METHODS: A computerised literature search was conducted to identify the relevant studies from the PUBMED and EMBASE databases, reviews, and reference lists of relevant articles. Odds ratios(ORs) with 95% confidence intervals(CIs) were used to assess the associations between the XPD Asp312 Asn and/or Lys751 Gln polymorphisms and EC susceptibility. Statistical analyses were performed using the software Stata 12.0. A fixed or random effects model was selected based on a heterogeneity test. Publication bias was estimated using funnel plots and Egger’s linear regression method. Subgroup analyses were performed based on histological type and ethnicity.RESULTS: Thirteen case-control studies with a total of 10 comparisons for the Asp312 Asn polymorphism, including 2373 cases and 3175 controls, and 15 comparisons for the Lys751 Gln polymorphism, including 3226 cases and 5237 controls, were recruited for the meta-analysis. In terms of the XPD Asp312 Asn polymorphism, significantly increased EC risks were identified in the Asp/Asn vs Asp/Asp comparison(OR = 1.17, 95%CI: 1.02-1.33, P = 0.03) and in the dominantmodel comparison(Asn/Asn+Asp/Asn vs Asp/Asp: OR = 1.18, 95%CI: 1.04-1.34, P = 0.01). However, no significant associations were found in the Asn/Asn vs Asp/Asp comparison(OR = 1.30, 95%CI: 1.00-1.70, P = 0.05) or in the recessive-model comparison(Asn/Asn vs Asp/Asn + Asp/Asp: OR = 1.17, 95%CI: 0.91-1.50, P = 0.22). In terms of the XPD Lys751 Gln polymorphism, a significant association with EC susceptibility was found under the recessive model(Gln/Gln vs Lys/Gln+Lys/Lys: OR = 1.21, 95%CI: 1.02-1.43, P = 0.03). However, no associations were identified in the other comparisons(co-dominant model: Lys/Gln vs Lys/Lys: OR = 1.11, 95%CI: 0.94-1.31, P = 0.20; Gln/Gln vs Lys/Lys: OR = 1.31, 95%CI: 0.98-1.75, P = 0.07; dominant model: OR = 1.14, 95%CI: 0.96-1.35, P = 0.14).CONCLUSION: The results of this meta-analysis suggest that the XPD Asp312 Asn and Lys751 Gln gene polymorphisms are associated with a significantly increased risk for EC.
AIM: To clarify the effects of the xeroderma pigmentosum group D (XPD) Asp312 Asn and Lys751 Gln gene polymorphisms on the risk of esophageal cancer (EC). METHODS: A computerized literature search was conducted to identify the relevant studies from the PUBMED and EMBASE Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the associations between the XPD Asp312 Asn and / or Lys751 Gln polymorphisms and EC susceptibility. Statistical analyzes were performed using the software Stata 12.0. A fixed or random effects model was selected based on a heterogeneity test. Publication bias was estimated using funnel plots and Egger’s linear regression method. Subgroup analyzes were performed based on histological type and ethnicity .RESULTS: Thirteen case-control studies with a total of 10 comparisons for the Asp312 Asn polymorphism, including 2373 cases and 3175 controls, and 15 comparisons for the Lys751 Gln polymorphism, including 3226 cases and 5237 controls, were recruited for the meta-analysis. In terms of the XPD Asp312 Asn polymorphism, significantly increased EC risks were identified in the Asp / Asn vs Asp / Asp comparison (OR = 1.17, 95% CI: 1.02 -1.33, P = 0.03) and in the dominantmodel comparison (Asn / Asn + Asp / Asn vs. Asp / Asp: OR = 1.18, 95% CI: 1.04-1.34, P = 0.01). However, no significant associations were found in the Asn / Asn vs Asp / Asp comparison (OR = 1.30, 95% CI: 1.00-1.70, P = 0.05) or in the recessive-model comparison (Asn / Asn vs. Asp / Asn + Asp / Asp: OR = 1.17, 95% CI: 0.91-1.50, P = 0.22). In terms of the XPD Lys751 Gln polymorphism, a significant association with EC susceptibility was found under the recessive model (Gln / Gln vs Lys / Gln + Lys / Lys: OR = 1.21 , 95% CI: 1.02-1.43, P = 0.03). However, no associations were identified in the other comparisons (co-dominant model: Lys / Gln vs. Lys / Lys: OR = 1.11, 95% CI: 0.94-1.31, P = 0.20; Gln / Gln vs. Lys / Lys: OR = 1.31, 95% CI: 0.98-1.75, P = 0.07; dominant model:OR = 1.14, 95% CI: 0.96-1.35, P = 0.14) .CONCLUSION: The results of this meta-analysis suggest that the XPD Asp312 Asn and Lys751 Gln gene polymorphisms are associated with a significantly increased risk for EC.